Improving emergency treatment for prolonged seizures
Prehospital Management of Status Epilepticus
This study looks at how emergency medical teams treat prolonged seizures, called status epilepticus, and aims to find out why they sometimes don't use important medications, like benzodiazepines, so they can improve care for patients having these serious seizures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11001643 on NIH RePORTER |
What this research studies
This research investigates how emergency medical services (EMS) manage status epilepticus, a severe condition characterized by prolonged seizures. It aims to identify the reasons behind the inconsistent use of benzodiazepines, which are critical for treating this condition, and to understand how these practices affect patient outcomes. By analyzing detailed EMS electronic medical records linked to hospital data, the study seeks to uncover factors that influence treatment decisions and ultimately improve care for patients experiencing status epilepticus.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who experience status epilepticus or are at risk of having prolonged seizures.
Not a fit: Patients with seizure disorders that do not involve status epilepticus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prehospital treatment protocols, reducing morbidity and mortality associated with status epilepticus.
How similar studies have performed: Previous research has shown that improving EMS protocols can enhance patient outcomes in emergency situations, suggesting that this approach has potential for success.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Guterman, Elan — University of California, San Francisco
- Study coordinator: Guterman, Elan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.